908 Devices (MASS) Q4 2025 Earnings Transcript Image source: The Motley Fool.DateTuesday, March 3, 2026 at 8:30 a.m. ETCall participantsChief Executive Officer and Co-Founder — Kevin J.…
Repligens Q4 Earnings Beat Estimates, Revenues Surge Y/Y RGEN tops Q4 EPS estimates as revenues jump 18% Y/Y, with solid organic growth and stronger margins heading into 2026.…
Repligens Q4 Earnings Beat Estimates, Revenues In Line RGEN reports decent fourth-quarter results and issues guidance for 2025.…
Repligens Q4 Slightly Tops Expectations The bioprocessing technology specialists fourth-quarter results were dragged down by restructuring costs.…
After-hours movers: Steelcase, Hess Midstream Partners, Repligen By Investing.com After-hours movers: Steelcase, Hess Midstream Partners, Repligen…
Maravai Lifesciences Shares Soar After Reported Takeover Offer Maravai Lifesciences Holdings Inc. shares soared after a report that the company received a takeover offer from Repligen Corp.…
Repligens (RGEN) Q2 Earnings & Revenues Meet Estimates Repligens (RGEN) second-quarter earnings and revenues match estimates. The company narrows its revenue guidance for 2024. Stock rises.…